Clinical Trial Services
FDA Standard Next Gen
DNA Sequencing
FDA Standard Sequencing
FDA Standard qPCR
FDA Standard Microarray
FDA Standard Microbial ID
Companion Diagnostics
Genetic Stability Testing
Biorepository
Biomarker Discovery
 
Research Services
Next Gen DNA Sequencing
Seq Capture Array & Genomic Enrichment
Sanger DNA Sequencing
Custom Molecular
Genetics & Genomics
Microarray Services
Expression Analysis

 

 


Quality Assurance Program

Regulatory Compliance

SeqWright developed and implemented a comprehensive Quality Assurance (QA) Program in 1999 to better support its growing base of pharma and biotech clients, with Quality Systems built around the Food & Drug Administration (FDA) guidelines described in section 21 of the Federal Code. These guidelines include regulations governing non-clinical Good Laboratory Practices (GLP), electronic signatures, and drug manufacturing.  Additionally, SeqWright is CLIA certified for the receipt and analysis of patient samples.

With a myriad of regulatory submission quality projects completed and numerous successful facility audits occurring each year, SeqWright is uniquely positioned, with the required experience and expertise, to perform your GLP projects in the most efficient and timely manner possible.

quality

Contact a sales representative about this Program.